A New Cardiologist's OPPE Flag and a Conflict of Interest
Dr. P, an interventional cardiologist, joined seven months ago with newly granted percutaneous coronary intervention privileges. Ongoing professional practice evaluation data for the first two quarters show 24 cases, 2 in-hospital deaths against an expected 0.9, 3 unplanned returns to the catheterization lab within 24 hours, and a door-to-balloon median of 71 minutes against a target of 90. The risk-adjusted mortality flag triggers at the 95th percentile, but the 95% confidence interval overlaps the expected rate. A charge nurse emailed the CNO that Dr. P "rushes and doesn't listen to the team" and that a technician was told to "stop questioning him." Dr. P's spouse is the cardiology department's quality analyst who compiled the OPPE report. The MEC meets in 12 days and wants a recommendation. The department chair favors immediate suspension "to be safe."
1. Is Dr. P an outlier, and what does the data actually support?
Read the worked answer
Not yet, and the chair's instinct to suspend is premature. With 24 cases and 2 deaths the expected count is under 1, so the observed-to-expected ratio is unstable; a confidence interval that overlaps the expected rate means the flag is a signal to look, not a finding of incompetence. The 3 returns to the lab and the door-to-balloon median may be more informative, but they need case-mix and denominator review before any conclusion.
Two process problems contaminate the review. The analyst who compiled the OPPE report is Dr. P's spouse, which is a conflict under the medical staff's own policy and undermines the credibility of the data regardless of whether the analysis was correct. The staff-relations complaint is unverified hearsay from a single source and cannot carry weight by itself.
The defensible conclusion is: insufficient evidence to act on privileges, sufficient evidence to trigger a focused evaluation. Suspending on this record invites a hearing the hospital may lose and, if the suspension exceeds 30 days, creates an NPDB-reportable event that follows Dr. P for the rest of his career.
2. Design the next step: what evaluation, by whom, with what metrics and timeline?
Read the worked answer
Use a focused professional practice evaluation triggered by the OPPE signal-distinct from the initial focused evaluation for new privileges, which is a separate mechanism. Steps: (1) recuse the spouse from every phase and have an independent analyst re-run the report from source data; (2) assign an uninvolved interventional cardiologist, or an external reviewer if the department is too small, to perform a structured review of all 24 cases plus the three returns against explicit criteria: indication, lesion complexity, stent selection, anticoagulation, closure technique, and documentation; (3) interview the catheterization lab team with a standard question set so the review is not built around one complaint; (4) define the evaluation period-typically 3 to 6 months or a set number of cases with 100% review-and specify in advance the criteria for resolution; (5) report progress to each MEC meeting; (6) define the three possible exits: return to routine OPPE, extend the evaluation, or refer for corrective action.
Write the plan before the data come in, with an owner and dates. Retrofit criteria invite the accusation that the outcome was decided first.
3. What conflicts and legal protections must be managed?
Read the worked answer
Conflicts first: document the spouse-analyst recusal and re-create the report, both because fairness requires it and because opposing counsel will use it. Confirm that the reviewing physician has no economic or personal conflict-in a small cardiology community, that may mean an external reviewer.
Legal protections: conduct and document the review as peer review under the state peer review statute, keep it out of the personnel file, and do not discuss it in open medical staff meetings. Procedural fairness matters even at this stage: tell Dr. P in writing that the evaluation is occurring, what triggered it, what the criteria are, and that he will have an opportunity to respond. If the evaluation results in a restriction lasting more than 30 days, HCQIA immunity requires adequate notice, a hearing, and an unbiased panel, so the evaluation must not become a de facto suspension without process.
Finally, manage the chair: the suspension recommendation is not supported by the data, and the MEC minutes should record that the focused evaluation was chosen instead of a privilege action, with the reasoning.